CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

NCT04375631 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fred Hutchinson Cancer Center

Collaborators